Overview

A Study To Investigate How The Body Handles Multiple Doses Of PF-0243873 And To Investigate The Effect Of PF-02413873 On Sex Hormone Levels In Healthy Young Women

Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
The study will investigate how well multiple doses of PF-02413873 are tolerated by healthy young women, how the body handles multiple doses of PF-02413873 and which effect PF-02413873 has on sex hormones in healthy young women
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer